TALIANI, GLORIA
 Distribuzione geografica
Continente #
NA - Nord America 1.259
EU - Europa 524
AS - Asia 100
AF - Africa 3
Totale 1.886
Nazione #
US - Stati Uniti d'America 1.254
GB - Regno Unito 172
IT - Italia 109
DE - Germania 86
SE - Svezia 69
UA - Ucraina 29
SG - Singapore 25
CN - Cina 23
TR - Turchia 20
HK - Hong Kong 18
BE - Belgio 11
FR - Francia 11
BG - Bulgaria 10
FI - Finlandia 10
ID - Indonesia 6
CA - Canada 3
ET - Etiopia 3
IN - India 3
PL - Polonia 3
RU - Federazione Russa 3
AL - Albania 2
AT - Austria 2
BZ - Belize 2
CZ - Repubblica Ceca 2
IL - Israele 2
JP - Giappone 2
LT - Lituania 2
AM - Armenia 1
CH - Svizzera 1
NL - Olanda 1
RO - Romania 1
Totale 1.886
Città #
Fairfield 225
Southend 148
Ashburn 118
Chandler 117
Seattle 100
Woodbridge 96
Houston 81
Wilmington 72
Modena 68
Cambridge 62
Ann Arbor 61
Dearborn 57
Nyköping 52
Jacksonville 44
Singapore 21
Izmir 19
New York 19
Hong Kong 18
San Diego 16
Brussels 11
Grafing 11
Eugene 10
Helsinki 10
Princeton 10
Sofia 10
Bremen 9
Redwood City 7
Leawood 6
Jakarta 5
Munich 5
Rome 5
Beijing 4
London 4
Addis Ababa 3
Boardman 3
Dallas 3
Monmouth Junction 3
Mumbai 3
Naples 3
San Mateo 3
Shanghai 3
Belize City 2
Chicago 2
Fremont 2
Kilburn 2
Los Angeles 2
Pozzo 2
Turin 2
Vienna 2
Amsterdam 1
Ankara 1
Atlanta 1
Brno 1
Calcinaia 1
Chiswick 1
Cilacap 1
Cividale Del Friuli 1
Falls Church 1
Indiana 1
Islington 1
Jinan 1
Kunming 1
Lanzhou 1
Maimatsubara 1
Markham 1
Milan 1
Modesto 1
Montréal 1
Mountain View 1
Nanchang 1
Napoli 1
Novokuznetsk 1
Olomouc 1
Ottawa 1
Polesella 1
Rho 1
Tel Aviv 1
Warsaw 1
Yerevan 1
Zurich 1
Totale 1.572
Nome #
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 299
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 273
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 194
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 192
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 186
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 167
From current status to optimization of HCV treatment: Recommendations from an expert panel 158
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 157
Current and future challenges in HCV: insights from an Italian experts panel 150
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 138
Totale 1.914
Categoria #
all - tutte 7.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.059


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020353 0 8 11 14 39 83 70 37 44 16 24 7
2020/2021525 31 7 26 55 66 46 122 34 30 59 38 11
2021/2022283 31 21 7 22 7 25 18 27 25 18 51 31
2022/2023279 44 38 30 33 27 31 9 26 19 1 11 10
2023/2024141 5 8 11 13 14 20 14 12 6 0 13 25
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 1.914